Intrathecal drug delivery (IDD) is an effective means to treat refractory pain of malignant and nonmalignant origin. In 2017, Polyanalgesic Consensus Conference guidelines were published to provide the physician with best practices to identify patients, stratify...
CITATION STYLE
Malinowski, M. N., Bremer, N., Kim, C. H., & Deer, T. R. (2019). Intrathecal Drug Delivery: Indications, Risks, and Complications. In Academic Pain Medicine (pp. 139–142). Springer International Publishing. https://doi.org/10.1007/978-3-030-18005-8_22
Mendeley helps you to discover research relevant for your work.